US Pharma MarketingRegeneron pays $37M, adds $2B in biobucks to expand CytomX pact
Regeneron pays $37M, adds $2B in biobucks to expand CytomX pact is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Regeneron has expanded its research alliance with CytomX Therapeutics, paying $37 million to work on conditionally active bispecifics against two targets and secure options on more programs. The expansion swells the potential value of the deal to about $4 billion.
Source: FierceBiotech